• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Kenvue (KVUE)

Sell: $17.82|Buy: $17.88|Change: 0.06 (-0.34%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, includingTylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Address




Website

https://www.kenvue.com

Sector 

Consumer Defensive

Forecast key dates

NameKey Date
Kenvue Inc Second Quarter Earnings Results for 20272027-08-06T00:00:00
Kenvue Inc Annual General Meeting for 20272027-05-21T09:00:00
Kenvue Inc First Quarter Earnings Results for 20272027-05-07T00:00:00
Kenvue Inc Annual Report for 20262027-02-19T00:00:00
Kenvue Inc Fourth Quarter Earnings Results for 20262027-02-17T00:00:00
Kenvue Inc Third Quarter Earnings Conference Call for 20262026-11-06T08:30:00
Kenvue Inc Third Quarter Earnings Results for 20262026-11-06T00:00:00

Previous key dates

NameKey Date
Kenvue Inc Second Quarter Earnings Results for 20262026-08-06T00:00:00
Kenvue Inc Annual General Meeting for 20262026-05-21T09:00:00
Kenvue Inc First Quarter Earnings Results for 20262026-05-07T00:00:00
Kenvue Inc Annual Report for 20252026-02-20T00:00:00
Kenvue Inc Fourth Quarter Earnings Results for 20252026-02-17T00:00:00
Kimberly-Clark Acquisition of Kenvue Conference Call2025-11-06T08:00:00
Kenvue Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.